| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/06/2005 | EP1520589A1 Erythropoietin in the treatment of domestic and livestock animals for anaemia |
| 04/06/2005 | EP1520050A2 Tr4/tr2 response elements |
| 04/06/2005 | EP1520044A2 Chromosome 6 and 9 genes involved in premature canities |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520042A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/06/2005 | EP1520032A2 Lung cancer therapeutics and diagnostics |
| 04/06/2005 | EP1520022A2 Rna-interference by single-stranded rna molecules |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1520014A2 Tocopherol associated protein and uses thereof |
| 04/06/2005 | EP1519957A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 04/06/2005 | EP1519745A1 Method to enhance an immune response of nucleic acid vaccination |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1278761B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1162993B1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP1097234B1 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
| 04/06/2005 | EP1040190B1 Serine proteinase inhibitors |
| 04/06/2005 | EP0847757B1 Medicine comprising hgf gene |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0663013B1 Method for delivering nucleic acids into cells |
| 04/06/2005 | CN1604963A Method for the in vitro synthesis of short double stranded RNAs |
| 04/06/2005 | CN1604906A Antisense antiviral agent and method for treating ssRNA viral infection |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1604789A Thymosin augmentation of genetic immunization |
| 04/06/2005 | CN1604783A Drug for treating a fibrotic disease through rna interfence |
| 04/06/2005 | CN1603404A Oncolytic adenovirus with target for liver cancer and its preparation method and use |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1602962A Complete virus gene engineering vaccine of aftosa and its preparation method |
| 04/06/2005 | CN1602957A Hybrid yeast AIDS vaccine |
| 04/06/2005 | CN1602816A Subsidiary nephric tubule device and its preparation and uses |
| 04/06/2005 | CN1195864C Slowviral vector |
| 04/06/2005 | CN1195863C Retroviral vectors |
| 04/06/2005 | CN1195860C Delivery of biologically active polypeptides |
| 04/06/2005 | CN1195852C Biotin-binding receptor molecules |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195502C Periadventitial delivery device |
| 04/05/2005 | US6875903 Nucleotide sequences coding polypeptide for use in the prevention of infections |
| 04/05/2005 | US6875853 Immunization of dairy cattle with chimeric GapC protein against streptococcus infection |
| 04/05/2005 | US6875844 Recombinant or chemically synthesized intestinal carboxyesterase (ICE)amino acid sequences for treating solid tumors |
| 04/05/2005 | US6875748 Sodium and potassium phosphate salts, in aqueous solution, and detergents and surfactants for direct polypeptide delivery into vertebrate cells |
| 04/05/2005 | US6875741 Insulin and IGF-1 receptor agonists and antagonists |
| 04/05/2005 | US6875612 Expression vector coding proteins for use in the treatment of tumors |
| 04/05/2005 | US6875611 Soluble steroidal peptides for nucleic acid delivery |
| 04/05/2005 | US6875610 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 04/05/2005 | US6875606 Human α-7 nicotinic receptor promoter |
| 04/05/2005 | US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease |
| 04/05/2005 | US6875598 Histone deacetylase-8 proteins, nuclei acids, and methods for use |
| 04/05/2005 | US6875587 Human protease inhibitor and polynucleotides encoding the same |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875569 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 04/05/2005 | US6875567 Identifying genes associated with hypertrophic cardiac tissue for diagnosis, prognosis, prevention and treatment of cardiovascular disorders |
| 04/01/2005 | CA2444161A1 A screening method of drug for treatment of neuropathic pain |
| 03/31/2005 | WO2005028658A2 Recombinant influenza vectors with a polii promoter and ribozymes |
| 03/31/2005 | WO2005028649A1 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/31/2005 | WO2005028633A2 Modulation of rankl expression |
| 03/31/2005 | WO2005028024A1 Delivering genetic material to a stimulation site |
| 03/31/2005 | WO2005027980A1 Rna interference for the treatment of gain-of-function disorders |
| 03/31/2005 | WO2005027979A2 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 03/31/2005 | WO2005027962A1 4’-thionucleosides and oligomeric compounds |
| 03/31/2005 | WO2005027848A2 Methods for screening osteogenic compounds targeting syk kinase and/or vav3 and uses of syk modulators and/or vav modulators |
| 03/31/2005 | WO2005027844A2 Dna vaccine compositions and methods of use |
| 03/31/2005 | WO2005027833A2 Compound and method for treating androgen-independent prostate cancer |
| 03/31/2005 | WO2005027807A1 Pharmaceutical delivery system |
| 03/31/2005 | WO2005019259A3 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 03/31/2005 | WO2005009355A3 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 03/31/2005 | WO2004110371A3 Method for the treatment of malignancies |
| 03/31/2005 | WO2004098508A3 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells |
| 03/31/2005 | WO2004096140A3 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 03/31/2005 | WO2004094605A3 Methods and compositions for inhibiting stat signaling pathways |
| 03/31/2005 | WO2004094466A3 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 03/31/2005 | WO2004081189A3 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 03/31/2005 | WO2004067719A3 Growth hormone releasing hormone (ghrh) for use in reducing culling in herd animals |
| 03/31/2005 | WO2004064711A3 Modulation of deubiquitinase family members |
| 03/31/2005 | WO2004048522A3 Modulation of huntingtin interacting protein 2 expression |
| 03/31/2005 | WO2004048325A3 Modulation of jagged 1 expression |
| 03/31/2005 | WO2004045547A3 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 03/31/2005 | WO2004036221A3 Compositions and methods for diagnosing and treating autoimmune disease |
| 03/31/2005 | WO2003103605A3 Flexible vaccine assembly and vaccine delivery platform |
| 03/31/2005 | WO2003099215A3 Antisense modulation of glucocorticoid receptor expression |
| 03/31/2005 | WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/31/2005 | WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use |
| 03/31/2005 | WO2002072753A3 Thymidylate synthase peptides that bind to thymidylate synthase messenger rna |
| 03/31/2005 | US20050071894 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 03/31/2005 | US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening |
| 03/31/2005 | US20050070670 Novel adjuvants and copolymer compositions |
| 03/31/2005 | US20050070493 Methods and compositions for treating Parkinson's disease |
| 03/31/2005 | US20050070492 Use of a ribozyme for inhibiting gene expression; screening for oligonucleotide antisense agents |
| 03/31/2005 | US20050070491 Immunostimulatory nucleic acid molecules |
| 03/31/2005 | US20050070474 Methods of treatment and compositions therefor |
| 03/31/2005 | US20050070462 Contacting with cationic polymer |
| 03/31/2005 | US20050070015 Methods of controlling proliferation of cancer cells and cell death |
| 03/31/2005 | US20050070014 Method of expressing foreign gene in kidney |
| 03/31/2005 | US20050069985 Assay methods and amelioration of muscular dystrophy symptoms |
| 03/31/2005 | US20050069981 Human vascular IBP-like growth factor |
| 03/31/2005 | US20050069960 Which induce proliferation of tumor-infiltrating lymphocytes without systemic toxicity associated with the administration of wild-type cytokines; drug screening/design |
| 03/31/2005 | US20050069946 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |